|
|
|
Volumn 23, Issue 2, 1996, Pages 220-228
|
|
Chemotherapy of adenocarcinoma of the pancreas
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACLACINOMYCIN;
ALTRETAMINE;
AMSACRINE;
ANTHRACYCLINE DERIVATIVE;
ANTINEOPLASTIC AGENT;
CAFFEINE;
CARMOFUR;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DIAZIQUONE;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
FLUOROURACIL;
GEMCITABINE;
IFOSFAMIDE;
MAYTANSINE;
MELPHALAN;
MENOGARIL;
METHOTREXATE;
MITOMYCIN C;
MITOXANTRONE;
NITROSOUREA DERIVATIVE;
RAZOXANE;
SEMUSTINE;
SPIROGERMANIUM;
STREPTOZOCIN;
UNINDEXED DRUG;
VINCRISTINE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER HORMONE THERAPY;
CANCER IMMUNOTHERAPY;
CANCER RESEARCH;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG SCREENING;
HUMAN;
INOPERABLE CANCER;
METASTASIS;
PANCREAS ADENOCARCINOMA;
PRIORITY JOURNAL;
REVIEW;
ADENOCARCINOMA;
ANTIBODIES, MONOCLONAL;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOLOGICAL RESPONSE MODIFIERS;
DEOXYCYTIDINE;
FLUOROURACIL;
GROWTH SUBSTANCES;
HUMANS;
OCTREOTIDE;
PACLITAXEL;
PALLIATIVE CARE;
PANCREATIC NEOPLASMS;
PROGNOSIS;
SURVIVAL RATE;
TAXOIDS;
|
|
EID: 0029874268
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (101)
|
|
References (0)
|
